Regeneron Pharma (REGN) PT Raised to $525 at Oppenheimer
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $803.48 -0.31%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 4 | New: 7
Join SI Premium – FREE
Oppenheimer analyst Hartaj Singh raised the price target on Regeneron Pharma (NASDAQ: REGN) to $525.00 (from $450.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Regeneron Pharma (REGN) PT Raised to $756 at Bernstein SocGen Group
- Hapag-Lloyd AG (HLAG:GR) (HPGLY) PT Raised to EUR115 at Citi
- Rolls-Royce Holdings Plc. (RR:LN) (RYCEY) PT Raised to GBP16.47 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
